Alternative activation of macrophages

Nature Reviews Immunology

Volumn 3, Issue 1, 2003, Pages 23-35

  Gordon, Siamon ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARGINASE; B7 ANTIGEN; CD23 ANTIGEN; CD86 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; GELATINASE B; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANNOSE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ALLERGY; CELL DIFFERENTIATION; CELL HETEROGENEITY; CYTOKINE PRODUCTION; HELPER CELL; HUMAN; IMMUNOREGULATION; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRYPANOSOMIASIS; ANIMAL; ANTIBODY PRODUCTION; IMMUNOLOGY; MOUSE; TH2 CELL;

ANIMALS; ANTIBODY FORMATION; CELL DIFFERENTIATION; CHEMOKINES; HUMANS; INTERLEUKIN-13; INTERLEUKIN-4; MACROPHAGE ACTIVATION; MICE; TH2 CELLS;

EID: 0037265240     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri978     Document Type: Review

References (129)

1. Mackaness, G. B. The immunological basis of acquired cellular resistance. J. Exp. Med. 120, 105 (1964). An earty delineation of macrophage activation by intracellular infection.
2. Gordon, S. in Fundamental Immunology 4th edn Ch. 15 (ed. Paul, W.) 533-545 (Lippincott Raven, Philadelphia, 1999).
3. Gordon, S. in Immunology 6th edn (eds Roltt, I., Brostoff, B. & Male, D.) 147-162 (Mosby, Edinburgh, 2001).
4. Hamilton, T. in The Macrophage 2nd edn (eds Burke, B. & Lewis, C. E.) 73-102 (Oxford Univ. Press, 2002).
5. Dalton, D. K. et al. Multiple defects of immune-cell function in mice with disrupted interferon-γ genes. Science 259, 1739-1742 (1993). The definitive proof that IFN-γ is a 'classical activator' of macrophage anti-microbial activity and is an inducer of the expression of MHC class II molecules and NOS2.
6. Ehrt, S. et al. Reprogramming of the macrophage transcriptome in response to interferon-γ and Mycobacterium tuberculosis. Signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J. Exp. Med. 194, 1123-1140 (2001).
7. Boldrick, J. C. et al. Stereotyped and specific gene-expression programs in human innate immune responses to bacteria. Proc. Natl Acad. Sci. USA 99, 972-977 (2002).
8. Nau, G. J. et al. Human macrophage activation programs induced by bacterial pathogens. Proc. Natl Acad. Sci. USA 99, 1503-1508 (2002).
9. Goerdt, S. & Orfanos, C. E. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10, 137-142 (1999).
10. H2 paradigm. J. Immunol. 164, 6166-6173 (2000).
11. Tzachanis, D., Berezovskaya, A., Nadler L. M. & Boussiotis, V. A. Blockade of B7/CD28 in mixed lymphocyte reaction cultures results in the generation of alternatively activated macrophages, which suppress T-cell responses. Blood 99, 1465-1473 (2002).
12. Peiser, L., Mukhopadhyay, S. & Gordon, S. Scavenger receptors in innate immunity. Curr. Opin. Immunol. 14, 123-128 (2002).
13. 2 and PAF. J. Clin. Invest. 101, 890-898 (1998).
14. Ravetch, J. V. & Bolland, S. IgG Fc receptors. Annu. Rev. Immunol. 19, 275-290 (2001).
15. Barrington, R, Zhang, M., Fischer, M. & Carroll, M. C. The role of complement in inflammation and adaptive immunity. Immunol. Rev. 180, 5-15 (2001)
16. Crouch, E. C. & Whitsett, J. A. in Innate Immunity (eds Ezekowitz, R. A. B. & Hoffman, J. A.) 205-229 (Humana, Totowa, New Jersey, 2002).
17. Tobias, R. A. in Innate Immunity (eds Ezekowitz, R. A. B. & Hoffman, J. A.) 255-265 (Humana, Totowa, New Jersey, 2002).
18. Kaisho, T. & Akira, S. in Innate Immunity (eds Ezekowitz, R. A. B. & Hoffman, J. A.) 177-189 (Humana, Totowa, New Jersey, 2002).
19. Linehan, S. A., Martinez-Pomares, L. & Gordon, S. Macrophage lectins in host defence. Microbes Infect. 2, 279-288 (2000).
20. de Fougerolles, A. R. et al. Global expression analysis of extracellular matrix-integrin interactions in monocytes. Immunity 13, 749-758 (2000).
21. Eggleton, P., Tenner, A. J. & Reid, K. M. M. C1q receptors. Clin. Exp. Immunol. 120, 406-412 (2000).
22. Brown, E. J. & Frazier, W. A. Integrin-associated protein (CD47) and its ligands. Trends Cell Biol. 11, 130-135 (2001).
23. Barclay, A. N., Wright, G. J., Brooke, G. & Brown, M. H. CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol. 213, 285-290 (2002)
24. Anderson, C. F. & Mosser, D. M. A novel phenotype for an activated macrophage: the type 2 activated macrophage. J. Leukocytes Biol. 72, 101-106 (2002).
25. Anderson, C. F. & Mosser, D. M. Cutting edge: biasing immune receptors by directing antigen to macrophage Fcγ receptors. J. Immunol. 168, 3697-3701 (2002).
26. Gerber, J. S. & Mosser, D. M. Reversing lipopolysaccharide toxicity by ligating the macrophage Fcγ receptors. J. Immunol. 166, 6861-6868 (2001).
27. Bach, E. A., Aguet, M. & Schreiber, R. D. The IFNγ receptor: a paradigm for cytokine receptor signalling. Annu. Rev. Immunol. 15, 563-591 (1997).
28. Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J. & Paul, W. E. The IL-4 receptor: signalling mechanisms and biologic functions. Annu. Rev. Immunol. 17, 701-738 (1999).
29. Moore, K. W., de Waal Malefyt, R., Coffman, R. L. & O'Garra, A. Interleukin-10 and the Interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765 (2001).
30. Tsuaawaki, S., Sporn, M., Ding, A. & Nathan, C. Deactivation of macrophages by transforming growth factor-β. Nature 334, 260 (1988).
31. O'Garra, A. & Arai, N. The molecular basis of T helper 1 and T helper 2 cell differeatiation. Trends Cell Biol. 10, 542-550 (2000).
32. H2 paradigm to all lymphocytes? Nature Immunol. 2, 899-900 (2001).
33. H1-specific cell-surface protein Tim-3 regulates macrophage activation and seventy of an autoimmune disease. Nature 415, 536-541 (2002).
34. H2 cell membrane factors in association with IL-4 enhance matrix metalloproteinase-1 (MMP-1) while decreasing MMP-9 production by granulocyte-macrophage colony-stimulating factor-differentiated human monocytes. J. Immunol. 164, 5952-5960 (2000)
35. Banchereau, J. et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811 (2000).
36. Shortman, K. & Liu, Y.-J. Mouse and human denddtic-cell subtypes, Nature Immunol. 2, 151-161 (2002). An up-to-date assessment of dendritic-cell heterogeneity.
37. Takeda, K., Kamanaka, M., Tanaka, T., Kishimoto, T. & Akira, S. Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice J. Immunol. 157, 3220-3222 (1996).
38. H2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380, 630-633 (1996).
39. H2 cells in IL-13-deficient mice. Immunity 9, 423-432 (1998).
40. Kopf, M., Le, G. G., Coyle, A. J., Kosco, V. M. & Brombacher, F. Immune responses of IL-4, IL-5, IL-6 deficient mice. Immunol. Rev. 148, 45-69 (1995).
41. McKenzie, G. J., Fallon, P., Emson, C. L., Grencis, R. & McKenzie, A. N. J. Simultaneous disrupton of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type-2-mediated responses. J. Exp. Med. 189, 1565-1572 (1999).
42. Mohrs, M. et al. Differences between IL-4- and IL-4 receptor-α -defcient mice in chronic Leishmaniasis reveal a protective role for IL-13 receptor signalling. J. Immunol. 162, 7302-7306 (1999).
43. Stein, M., Keshav, S., Harris, N. & Gordon, S. IL-4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176, 287-292 (1992). The first report of the upregulation of expression of macrophage mannose receptor by IL-4, and suggested use of the term 'alternative activation' to distinguish this mechanism from the previously reported downregulation of expression by IFN-γ.
44. McInnes, A. & Rennick, D. M. Interleukin-4 induces cultured monocytes/macrophages to form giant multinucleated cells. J. Exp. Med. 167, 598-611 (1988).
45. Mokoena, T. & Gordon, S. Activation of human macrophages, Modulation of mannosyl, fucosyl receptors for endocytosis by lymphokine, γ and α interferons and dexamethasone. J. Clin. Invest. 75, 624-631 (1985).
46. Doyle, A. G. et al. Interleukin-13 alters the activation state of munne macrophages in vitro: comparison with interleukin-4 and interferon-γ. Eur. J. Immunol. 24, 1441-1445 (1994).
47. 47. Doherty, T. M., Kastelein, R., Menon, S., Andrade, S. & Coffman, R. L. Modulation of murine macrophage function by IL-13. J. Immunol. 151, 7151-7160 (1993).
48. de Waal Malefyt, R. et al. Effects of IL-13 on phenotype, cytokine production and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-γ or IL-10. J. Immunol. 151, 6370-6381 (1993)
49. Hart, P. H. et al. Differential responses of human monocytes and macrophages to IL-4 and IL-13. Leukocyte Biol. 68, 575-578 (1999).
50. Montaner, L. J. et al. Type-1 and type-2 cytokine regulation of macrophage endocytosis: differential activation by IL-4/IL-13 as opposed to IFN-γ or IL-10. J. Immunol. 162, 4606-4613 (1999).
51. Prigozy, T. I. et al. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity 6, 187-197 (1997).
52. Sallusto, F., Cella, M., Daniell, C. & Lanzavecchia, A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389-400 (1995).
53. Martinez-Pomares, L. & Gordon, S. The mannose receptor and its role in antigen presentation. The Immunologist 7, 119-123 (1999).
54. Loke, P. et al. IL-4-dependent alternatively activated macrophages have a distinctive in vivo gene-expression phenotype. BMC Immunol. 3, 7 (2002).
55. H2-specific cytokine gene cluster. J. Immunol. 165, 6687-6691 (2000).
56. H-Cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nature Immunol. 3, 643-651 (2002).
57. Saccani, S., Pantano, S. & Natoli, G. Two waves of nuclear factor-κB recruitment to target promoters. J. Exp. Med. 193, 1351-1360 (2001).
58. Sallusto, F. & Lanzavecchia, A. Understanding dendritic-cell and T-lymphocyte traffic through the analysis of chemokine-receptor expression. Immunol. Rev. 177, 134-140 (2000).
59. Mantovani, A., Locat, M., Vecchi, A., Sozzani, S. & Allavena, P. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol. 22, 328-336 (2001).
60. Fenton, M. J., Buras, J. A. & Donnelly, R. P. IL-4 reciprocally regulated IL-1 and IL-1 receptor antagonist expression in human monocytes. J. Immunol. 149, 1283-1288 (1992).
61. H2-polarized responses, by a group that has made several important contributions to this field.
62. H2 cytokines IL-4 and IL-13. J. Immunol. 161, 5027-5038 (1998).
63. H2 cells toward antigen-presenting cells by the CC-chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int. Immunol. 11, 81-68 (1999).
64. Bonecchi, R. et al. Induction of functional IL-8 receptors by IL-4 and IL-13 in human monocytes. J. Immunol. 164, 3862-3869 (2000).
65. Gordon, S. & Hughes, D. A. in Lung Macrophages and Dendritic Cells in Health & Disease (eds Lipscomb, M. & Russell, S.) 3-31 (Marcel Dekker, New York, 1997)
66. Zhu, Z. et al. IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodelling. J. Immunol. 168, 2953-2962 (2002).
67. Traynor, T. R., Kuziel, W. A., Toews, G. B. & Huffnagle, G. B. CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection J. Immunol. 164, 2021-2027 (2000).
68. H2 polarization by the chemokine monocyte chemoattractant protein-1 Nature 404, 407-411 (2000).
69. Gao, J.-L. et al. Impaired host defense, hematopoiesis, granulomatous inflammation and type-1-type 2 cytokine balance in mice lacking CC-chemokine receptor 1. J. Exp. Med. 165, 1959-1968 (1997).
70. Medoff, B. D. et al. IFN-γ-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma. J. Immunol. 168, 5278-5286 (2002).
71. H2 cytokines and associated pathologies in the host.
72. H2 immune-cell recruitment and pathology.
73. Chensue, S. W., Warmington, K., Ruth, J. H., Lukacs, N. & Kunkel, S. L. Mycobacterial and schistosomal antigen-elicited granuloma formation in IFN-γ and IL-4 knockout mice: analysis of local and regional cytokine and chemokine networks. J. Immunol. 159, 3565-3573 (1997).
74. Warmington, K. S. et al. Effect of CC-chemokine receptor 2 (CCR2) knockout on type-2 (schistosomal antigen-elicited) pulmonary granuloma formation: analysis of cellular recruitment and cytokine responses. Am. J. Pathol. 154, 1407-1416 (1999).
75. Jankovic, D. et al. Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile. J. Immunol. 163, 337-342 (1999).
76. Rutschman, R. et al. Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production. J. Immunol. 166, 2173-2177 (2001).
77. H2 phenotype. J. Immunol. 160, 5347-5354 (1998).
78. H2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J. Immunol. 163, 3771-3777 (1999).
79. H2 model of granulomatous disease. Am. J. Pathol. 157, 945-955 (2000).
80. H2-cell activation, granuloma formation and repair.
81. Namangala, B., De Baetselier, P., Noel, W., Brys, L. & Beschin, A. Aternative versus classical macrophage activation during experimental African trypanosomosis. J. Leukocyte Biol. 69, 387-396 (2001).
82. Raes, G. et al. Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J. Leukocyte Biol. 71, 597-602 (2002).
83. H2 cytokines and allergic challenge induce Ym1 expression in macrophages by a STAT6-dependent mechanism. J. Biol. Chem. 277, 42821-42829 (2002).
84. Webb, D. C., McKenzie, A. N. & Foster, P. S. Expression of the Ym2 lectin-binding protein is dependent on interleukin (IL-4) and IL-13 signal transduction: identification of a novel allergy-associated protein. J. Biol. Chem. 276, 41969-41976 (2001).
85. Loke, P., MacDonald, A. S., Robb, A., Maizels, R. M. & Allen, J. E. Alternativety activated macrophages induced by nematode infection inhibit proliferation via cell-to-cell contact. Eur. J. Immunol. 30, 2669-2678 (2000).
86. H2 phenomenon? Immunol. Today 14, 353-356 (1993).
87. H2 cytokine environment of the placenta. Int. Arch. Allergy Immunol. 123, 107-119 (2000).
88. Mues, B., Langer, D., Zwadlo, G. & Sorg, C. Phenotypic charactenzation of macrophages in human term placenta. Immunology 67, 303-307 (1989).
89. Mellor, A. L. et al. Prevention of T-cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nature Immunol. 2, 64-68 (2001)
90. Bonney, E. A. & Matzinger, P. Much IDO about pregnancy. Nature Med. 4, 1128-1129 (1998).
91. Kodelja, V. et al. Differences in angiogenic potential of classically vs alternatively activated macrophages. Immunobiology 197, 478-493 (1997).
92. Albina, J. E., Mills, C. D., Henry, W. L. Jr & Caldwell, M. D. Temporal expression of different pathways of L-arginine metabolism in healing wounds. J. Immunol. 144, 3877 (1990).
93. Andersson, P.-B., Perry, V. H. & Gordon, S. The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience 48, 169-186 (1992).
94. Glass, C. K. & Witztum, J. L. Atherosclerosis, the road ahead. Cell 104, 503-516 (2001). An overview of atherosclerosis as a modified form of inflammatory response, in which macrophages have an important role.
95. Gupta, S. et al. IFN-γ potentiated atherosclerosis in ApoE knock-out mice. J. Clin. Invest. 99, 2752-2761 (1997).
96. Greaves, D. R. et al. Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 21, 923-929 (2001).
97. Huang, J. T. et al. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase. Nature 400, 378-382 (1999).
98. Balkwill, F. R. & Mantovani, A. Inflammation and cancer: back to Virchow? Lancet 357, 539-545 (2001).
99. Kapp, U. et al. Interleukin-13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J. Exp. Med. 189, 1939-1945 (1999).
100. van den Berg, A., Visser, L. & Poppema, S. High expression of the CC-chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. Am. J. Pathol. 154, 1885-1691 (1999).
101. Schutyser, E. et al. Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation regulated chemokine in ovarian carcinoma. J. Biol. Chem. 277, 24584-24593 (2002).
102. Lin, E. Y., Nguyen, A. V., Russell, R. G. & Pollard, J. W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193, 727-740 (2001).
103. Nowicki, A. et al. Impaired tumor growth in colony-stimulating factor 1 (CSF-1)-deficient, macrophage-deficient op/op mouse: evidence for a role of CSF-1-dependent macrophages in formation of tumor stroma. Int. J. Cancer 65, 112-119 (1996).
104. Crowther, M., Brown, N. J., Bishop, E. T. & Lewis, C. E. Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J. Leukocyte Biol. 70, 478-490 (2001).
105. Geldhof, A. B. et al. Antagonistic effect of NK cells on alternatively activated monocytes: a contribution of NK cells to CTL generation. Blood 100, 4049-4058 (2002).
106. Chiaramonte, M. G., Donaldson, D. D., Cheever, A. W. & Wynn, T. A. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J. Clin. Invest. 104, 777-785 (1999).
107. Stacey, M., Lin, H.-H., Gordon, S. & McKnight, A. J. LNB-TM7, a novel group of seven-transmembrane proteins related to family-B G-protein-coupled receptors. Trends Biochem. Sci. 25, 284-289 (2000).
108. Randolph, G. J. Dendritic-cell migration to lymph nodes: cytokines, chemokines and lipid mediators. Semin. Immunol. 13, 267-274 (2001).
109. Loots, G. G. et al. Identification of a co-ordinate regulator of interleukins 4, 13 and 5 by cross-species sequence comparisons. Science 288, 136-140 (2000).
110. Mohrs, M. et al. Deletion of a co-ordinate regulator of type-2 cytokine expression in mice. Nature Immunol. 2, 826-828 (2001).
111. Lee, G. R., Fields, P. E. & Flavell, R. A. Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level. Immunity 14, 447-459 (2001).
112. H2 differentiation. J. Immunol. 169, 847-650 (2002).
113. H2 responses even in the combined absence of IL-5, IL-9 and IL-13. Immunity 17, 7-17 (2002).
114. Brubaker, J. O. & Montaner, L. J. Role of interleukin-13 in innate and adaptive immunity. Cell. Mol. Biol. 47, 637-651 (2000).
115. Brombacher, F. The role of interleukin-13 in infectious diseases and allergy. BioEssays 22, 646-656 (2000). A comprehensive review of the production of IL-13 and its role in wild-type and gene-knockout animal models.
116. Donnelly, R. P., Dickensheets, H. & Finbloom, D. S. The interleukin-10 signal-transduction pathway and regulation of gene expression in mononuclear phagocytes. J. Interferon Cytokine Res. 19, 563-573 (1999).
117. Lang, R., Rutschman, R. L., Greaves, D. R. & Murray, P. J. Autocrine deactivation of macrophages in transgenic mice constitutively overexpressing IL-10 under control of the human CD68 promoter. J. Immunol. 168, 3402-3411 (2002).
118. Lang, R., Patel, D., Morris, J. J., Rutschman, R. L. & Murray, P. J. Shaping gene expression in activated and resting primary macrophages by IL-10. J. Immunol. 169, 2253-2263 (2002).
119. East, L. & Isacke, C. M. The mannose-receptor family. Biochem. Biophys. Acta. 1572, 364-386 (2002).
120. Lee, S. J. et al. Mannose receptor-mediated regulation of serum glycoprotein homeostasis. Science 295, 1898-1901 (2002).
121. Martinez-Pomares, L. et al. Cell-specific glycoforms of sialoadhesin and CD45 are counter receptors for the cysteine-rich domain of the mannose receptor. J. Biol. Chem. 274, 35211-35218 (1999).
122. Becker, S. & Daniel, E. G. Antagonistic and additive effects of IL-4 and IFN-γ on human monocytes and macrophages: effects on Fc receptors, HLA-D antigens and superoxide production. Cell. Immunol. 129, 351-362 (1990).
123. Kristiansen, M. et al. Identification of the haemoglobin scavenger receptor. Nature 409, 198-201 (2001).
124. Goerdt, S., Walsh, L. J., Murphy, G. F. & Pober, J. S. Identification of a novel high molecular weight protein preferentially expressed by sinusoidal endothelial cells in normal human tissues. J. Cell. Biol. 113, 1425-1437 (1991).
125. Gratchev, A. et al. Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein βIG-H3. Scand. J. Immunol. 53, 386-392 (2001).
126. H2-associated expression pattern. J. Immunol. 160, 1411-1418 (1998).
127. Kambayashi, T., Jacob, C. O. & Strassmann, G. IL-4 and IL-13 modulate IL-10 release in endotoxin-stimulated murine peritoneal mononuclear phagocytes. Cell. Immunol. 171, 153-158 (1996).
128. Lee, C. G. et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor-β1. J. Exp. Med. 194, 809-821 (2001).
129. Conrad, D. J., Kuhn, H., Mulkins, M., Highland, E. & Sigal, E. Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc. Natl Acad. Sci. USA 89, 217-221 (1992).